Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Keywords:
BCR/ABL tyrosine kinase inhibitor
Bosutinib
Ponatinib
Imatinib
Nilotinib
Dasatinib
Chronic myeloid leukemia
Pharmacology
Note:
This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Citation:
Azanza, J.R. (José Ramón); Sadaba, B. (Belén); Díez, N. (Nieves). "Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia". International journal of clinical pharmacology & pharmacotherapy. 3 (134), 2018,
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.